{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:53:58Z","timestamp":1794322438280,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40120-022-00408-x","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T20:02:56Z","timestamp":1667419376000},"page":"107-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient\u2019s Perspective: A Qualitative Study"],"prefix":"10.1007","volume":"12","author":[{"given":"Kristi","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Parthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Lauher-Charest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"11","key":"408_CR1","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/jci29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006;116(11):2843\u201354. https:\/\/doi.org\/10.1172\/jci29894.","journal-title":"J Clin Invest"},{"issue":"1","key":"408_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/nyas.13522","volume":"1412","author":"JF Howard Jr","year":"2018","unstructured":"Howard JF Jr. Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci. 2018;1412(1):113\u201328. https:\/\/doi.org\/10.1111\/nyas.13522.","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"408_CR3","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","volume":"263","author":"N Melzer","year":"2016","unstructured":"Melzer N, Ruck T, Fuhr P, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016;263(8):1473\u201394. https:\/\/doi.org\/10.1007\/s00415-016-8045-z.","journal-title":"J Neurol"},{"issue":"1","key":"408_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1159\/000311012","volume":"35","author":"CH Lai","year":"2010","unstructured":"Lai CH, Tseng HF. Nationwide population-based epidemiological study of myasthenia gravis in Taiwan. Neuroepidemiology. 2010;35(1):66\u201371. https:\/\/doi.org\/10.1159\/000311012.","journal-title":"Neuroepidemiology"},{"issue":"11","key":"408_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1819","volume":"10","author":"E Westerberg","year":"2020","unstructured":"Westerberg E, Punga AR. Epidemiology of myasthenia gravis in Sweden 2006\u20132016. Brain Behav. 2020;10(11):e01819. https:\/\/doi.org\/10.1002\/brb3.1819.","journal-title":"Brain Behav"},{"key":"408_CR6","unstructured":"National Institute of Neurological Disorders and Stroke. Myasthenia gravis fact sheet. 2020. https:\/\/www.ninds.nih.gov\/Disorders\/Patient-Caregiver-Education\/Fact-Sheets\/Myasthenia-Gravis-Fact-Sheet. Accessed 16 June 2021."},{"issue":"1","key":"408_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, et al. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30. https:\/\/doi.org\/10.1038\/s41572-019-0079-y.","journal-title":"Nat Rev Dis Primers"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"175628641983224","DOI":"10.1177\/1756286419832242","volume":"12","author":"C Schneider-Gold","year":"2019","unstructured":"Schneider-Gold C, Hagenacker T, Melzer N, Ruck T. Understanding the burden of refractory myasthenia gravis. Ther Adv Neurol Disord. 2019;12:1756286419832242. https:\/\/doi.org\/10.1177\/1756286419832242.","journal-title":"Ther Adv Neurol Disord"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","volume":"10","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021;10:2235. https:\/\/doi.org\/10.3390\/jcm10112235.","journal-title":"J Clin Med"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1007\/s00415-021-10902-1","volume":"268","author":"LK Andersen","year":"2021","unstructured":"Andersen LK, Jakobsson AS, Revsbech KL, Vissing J. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis. J Neurol. 2021;269:3086\u201393. https:\/\/doi.org\/10.1007\/s00415-021-10902-1.","journal-title":"J Neurol"},{"issue":"14","key":"408_CR11","doi-asserted-by":"publisher","first-page":"e1382","DOI":"10.1212\/wnl.0000000000012604","volume":"97","author":"M Petersson","year":"2021","unstructured":"Petersson M, Feresiadou A, Jons D, et al. Patient-reported symptom severity in a nationwide myasthenia gravis cohort: cross-sectional analysis of the Swedish GEMG study. Neurology. 2021;97(14):e1382\u201391. https:\/\/doi.org\/10.1212\/wnl.0000000000012604.","journal-title":"Neurology"},{"key":"408_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J, P\u00f6hlau D, Kugler J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes. 2010;8:129. https:\/\/doi.org\/10.1186\/1477-7525-8-129.","journal-title":"Health Qual Life Outcomes"},{"key":"408_CR13","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1007\/s00415-021-10891-1","volume":"269","author":"S Lehnerer","year":"2021","unstructured":"Lehnerer S, Jacobi J, Schilling R, et al. Burden of disease in myasthenia gravis: taking the patient\u2019s perspective. J Neurol. 2021;269:3050\u201363. https:\/\/doi.org\/10.1007\/s00415-021-10891-1.","journal-title":"J Neurol"},{"key":"408_CR14","unstructured":"US Food and Drug Administration. Patient-focused drug development: collecting comprehensive and representative input. Guidance for industry, Food and Drug Administration staff, and other stakeholders. 2020. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-collecting-comprehensive-and-representative-input. Accessed 30 June 2020."},{"key":"408_CR15","unstructured":"US Food and Drug Administration. Patient-focused drug development: methods to identify what is important to patients. Guidance for industry, Food and Drug Administration staff, and other stakeholders. 2022. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-methods-identify-what-important-patients. Accessed 3 Mar 2022."},{"key":"408_CR16","unstructured":"US Food and Drug Administration. CDER patient-focused drug development. 2022. https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/cder-patient-focused-drug-development. Accessed 3 Mar 2022."},{"issue":"8","key":"408_CR17","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1\u2014eliciting concepts for a new PRO instrument. Value Health. 2011;14(8):967\u201377. https:\/\/doi.org\/10.1016\/j.jval.2011.06.014.","journal-title":"Value Health"},{"issue":"1","key":"408_CR18","doi-asserted-by":"publisher","first-page":"160940691770298","DOI":"10.1177\/1609406917702983","volume":"16","author":"KKF Cheng","year":"2017","unstructured":"Cheng KKF, Clark AM. Qualitative methods and patient-reported outcomes: measures development and adaptation. Int J Qual Methods. 2017;16(1):1609406917702983. https:\/\/doi.org\/10.1177\/1609406917702983.","journal-title":"Int J Qual Methods"},{"key":"408_CR19","volume-title":"Basics of qualitative research: grounded theory procedures and techniques","author":"AL Strauss","year":"1990","unstructured":"Strauss AL, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park: Sage Publications; 1990."},{"key":"408_CR20","volume-title":"Qualitative inquiry and research design: choosing among five approaches","author":"JW Creswell","year":"2013","unstructured":"Creswell JW. Qualitative inquiry and research design: choosing among five approaches. Los Angeles: SAGE Publications; 2013."},{"issue":"1","key":"408_CR21","first-page":"7","volume":"1","author":"JA Wolf","year":"2014","unstructured":"Wolf JA, Niederhauser V, Marshburn D, LaVela SL. Defining patient experience. Patient Exp J. 2014;1(1):7\u201319.","journal-title":"Patient Exp J"},{"issue":"7","key":"408_CR22","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/wnl.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, et al. Myasthenia gravis activities of daily living profile. Neurology. 1999;52(7):1487\u20139. https:\/\/doi.org\/10.1212\/wnl.52.7.1487.","journal-title":"Neurology"},{"key":"408_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1177\/1744987117741667","volume":"23","author":"A Assarroudi","year":"2018","unstructured":"Assarroudi A, Heshmati Nabavi F, Armat M, Ebadi A, Vaismoradi M. Directed qualitative content analysis: the description and elaboration of its underpinning methods and data analysis process. J Res Nurs. 2018;23:42\u201355. https:\/\/doi.org\/10.1177\/1744987117741667.","journal-title":"J Res Nurs"},{"key":"408_CR24","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research: Princeton: Recording for the Blind & Dyslexic; 2008."},{"key":"408_CR25","volume-title":"Basics of qualitative research: techniques and procedures for developing grounded theory","author":"JM Corbin","year":"2009","unstructured":"Corbin JM, Strauss AL. Basics of qualitative research: techniques and procedures for developing grounded theory. 3rd ed. Los Angeles: Sage Publications; 2009.","edition":"3"},{"issue":"7","key":"408_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jval.2017.11.014","volume":"21","author":"DM Turner-Bowker","year":"2018","unstructured":"Turner-Bowker DM, Lamoureux RE, Stokes J, et al. Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development. Value Health. 2018;21(7):839\u201342. https:\/\/doi.org\/10.1016\/j.jval.2017.11.014.","journal-title":"Value Health"},{"issue":"5","key":"408_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098089","volume":"9","author":"C Barnett","year":"2014","unstructured":"Barnett C, Bril V, Kapral M, Kulkarni A, Davis AM. A conceptual framework for evaluating impairments in myasthenia gravis. PLoS ONE. 2014;9(5): e98089. https:\/\/doi.org\/10.1371\/journal.pone.0098089.","journal-title":"PLoS ONE"},{"issue":"2","key":"408_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s40120-021-00285-w","volume":"10","author":"N Law","year":"2021","unstructured":"Law N, Davio K, Blunck M, Lobban D, Seddik K. The lived experience of myasthenia gravis: a patient-led analysis. Neurol Ther. 2021;10(2):1103\u201325. https:\/\/doi.org\/10.1007\/s40120-021-00285-w.","journal-title":"Neurol Ther"},{"issue":"1","key":"408_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12883-016-0757-2","volume":"16","author":"A Frost","year":"2016","unstructured":"Frost A, Svendsen ML, Rahbek J, et al. Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1997\u20132011: a Danish nationwide cohort study. BMC Neurol. 2016;16(1):224. https:\/\/doi.org\/10.1186\/s12883-016-0757-2.","journal-title":"BMC Neurol"},{"issue":"4","key":"408_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000506310","volume":"54","author":"E Guastafierro","year":"2020","unstructured":"Guastafierro E, Tramacere I, Toppo C, et al. Employment in myasthenia gravis: a systematic literature review and meta-analysis. Neuroepidemiology. 2020;54(4):304\u201312. https:\/\/doi.org\/10.1159\/000506310.","journal-title":"Neuroepidemiology"},{"issue":"6","key":"408_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.26694","volume":"60","author":"L Harris","year":"2019","unstructured":"Harris L, Aban IB, Xin H, Cutter G. Employment in refractory myasthenia gravis: a Myasthenia Gravis Foundation of America Registry analysis. Muscle Nerve. 2019;60(6):700\u20136. https:\/\/doi.org\/10.1002\/mus.26694.","journal-title":"Muscle Nerve"},{"issue":"2","key":"408_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013278","volume":"7","author":"Y Nagane","year":"2017","unstructured":"Nagane Y, Murai H, Imai T, et al. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 2017;7(2): e013278. https:\/\/doi.org\/10.1136\/bmjopen-2016-013278.","journal-title":"BMJ Open"},{"issue":"4","key":"408_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5694\/j.1326-5377.1998.tb126776.x","volume":"168","author":"CD Mathers","year":"1998","unstructured":"Mathers CD, Schofield DJ. The health consequences of unemployment: the evidence. Med J Aust. 1998;168(4):178\u201382. https:\/\/doi.org\/10.5694\/j.1326-5377.1998.tb126776.x.","journal-title":"Med J Aust"},{"issue":"12","key":"408_CR34","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.2105\/ajph.94.12.2155","volume":"94","author":"M Voss","year":"2004","unstructured":"Voss M, Nyl\u00e9n L, Floderus B, Diderichsen F, Terry PD. Unemployment and early cause-specific mortality: a study based on the Swedish twin registry. Am J Public Health. 2004;94(12):2155\u201361. https:\/\/doi.org\/10.2105\/ajph.94.12.2155.","journal-title":"Am J Public Health"},{"issue":"5","key":"408_CR35","first-page":"529","volume":"153","author":"RL Jin","year":"1995","unstructured":"Jin RL, Shah CP, Svoboda TJ. The impact of unemployment on health: a review of the evidence. CMAJ. 1995;153(5):529\u201340.","journal-title":"CMAJ"},{"issue":"4","key":"408_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1177\/1039856215618523","volume":"24","author":"M Modini","year":"2016","unstructured":"Modini M, Joyce S, Mykletun A, et al. The mental health benefits of employment: results of a systematic meta-review. Australas Psychiatry. 2016;24(4):331\u20136. https:\/\/doi.org\/10.1177\/1039856215618523.","journal-title":"Australas Psychiatry"},{"issue":"2","key":"408_CR37","first-page":"109","volume":"39","author":"G Waddell","year":"2007","unstructured":"Waddell G, Burton K, Aylward M. Work and common health problems. J Insur Med. 2007;39(2):109\u201320.","journal-title":"J Insur Med"},{"key":"408_CR38","doi-asserted-by":"publisher","unstructured":"Keer-Keer T. The lived experience of adults with myasthenia gravis: a phenomenological study. Australas J Neurosci. 2015;25(1):40\u20136. https:\/\/doi.org\/10.21307\/ajon-2017-112.","DOI":"10.21307\/ajon-2017-112"},{"issue":"4","key":"408_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/mus.24213","volume":"50","author":"K Utsugisawa","year":"2014","unstructured":"Utsugisawa K, Suzuki S, Nagane Y, et al. Health-related quality-of-life and treatment targets in myasthenia gravis. Muscle Nerve. 2014;50(4):493\u2013500. https:\/\/doi.org\/10.1002\/mus.24213.","journal-title":"Muscle Nerve"},{"issue":"6","key":"408_CR40","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jval.2020.01.019","volume":"23","author":"RL Harrington","year":"2020","unstructured":"Harrington RL, Hanna ML, Oehrlein EM, et al. Defining patient engagement in research: results of a systematic review and analysis: report of the ISPOR Patient-Centered Special Interest Group. Value Health. 2020;23(6):677\u201388. https:\/\/doi.org\/10.1016\/j.jval.2020.01.019.","journal-title":"Value Health"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-022-00408-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-022-00408-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T15:22:57Z","timestamp":1673536977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-022-00408-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s40120-022-00408-x","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}